Funding Rounds
Neurosterix Series A (2024, $63M)
NeurosterixAdvanced allosteric modulator therapeutics developer for neurological disorders.
Summary
Stage: Series A
Raised Amount: $63.00M
Raised Date: 2024-03-01
Stage: Series A
Raised Amount: $63.00M
Raised Date: 2024-03-01